About the project

 

V.A. Cure is a European MSCA-ITN network aiming to uncover core mechanisms of initiation and maintenance of Vascular Anomalies (VAs) and to leverage this information for establishing novel therapeutic strategies. The network consortium consists of 7 academic laboratories and 2 companies from across Europe, and is supported by 8 partner organisations (5 companies, one university, one hospital and a patient organization).

The 14 Early Stage Researchers (ESRs) will be a part of  the unique international PhD program, consisting of an individual research project, the network’s training programme, intersectoral secondments and outreach activities. Project goal is to  ensure a comprehensive perception of the research and drug/technology development in pharma industry/biotech and academia.

The individual research is a part of the V.A. Cure project, which is developed in four stages:

14 Early Stage Researchers to research the causes and mechanisms of aberrant vascular function   A comprehensive training programme provided by experts in vascular biology from across Europe   International cooperation on vascular anomalies research with participating organisations from across the whole chain

News

  • Deadline extended for the position ESR11

    Application process for the PhD position ESR 11: Dissecting the role of FOXO transcription factors in venous and lymphatic malformations  at Max Planck Institute for Heart and Lung Research is still open. The new deadline for the application is 30th of June 2019

  • Deadline extended

    The deadline for applications for the PhD student positions has been extended to 22 May 2019. Early Stage Researchers are invited to apply for the 14 positions. Please see elsewhere on this website for an overview of the positions and how to apply.

  • PhD positions open for application

    Applications are invited for the 14 PhD student positions in the V.A. Cure network. Have a look at the advertisement for more information and an overview of the positions. The deadline for application is 1 May 2019.

V.A. Cure Retweeted ·
Miikka. Vikkula
@MiikkaVikkula



This was a great add on to our understanding on appearance of #vascular anomalies in some individuals and surely to be taken into account in genetic counselling as you pointed out. Great to work with you and your team. #vacure #vascern #deduveinstitute https://t.co/48hDFmue8L

View on Twitter

5

0

Follow us on Facebook

Project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 814316